A GREAT SHOT STORMPINS A
PA
CORONAVIRUS CASES ARE RISING
PA
CORONAVIRUS CASES ARE RISING
ACROSS MORE THAN HALF OF THE
CORONAVIRUS CASES ARE RISING
ACROSS MORE THAN HALF OF THE
NATION 92% IN IOWA, EVEN AS
ACROSS MORE THAN HALF OF THE
NATION 92% IN IOWA, EVEN AS
THE OUTBREAK SLOWS ACROSS
NATION 92% IN IOWA, EVEN AS
THE OUTBREAK SLOWS ACROSS
FORMER HOT SPOTS THAT INCLUDES
THE OUTBREAK SLOWS ACROSS
FORMER HOT SPOTS THAT INCLUDES
HERE IN FLORIDA. ARIZONA
FORMER HOT SPOTS THAT INCLUDES
HERE IN FLORIDA. ARIZONA
CALIFORNIA
HERE IN FLORIDA. ARIZONA
CALIFORNIA
AND TEXAS. DOCTOR ASHISH JHA
CALIFORNIA
AND TEXAS. DOCTOR ASHISH JHA
DIRECTOR OF THE HARVARD GLOBAL
AND TEXAS. DOCTOR ASHISH JHA
DIRECTOR OF THE HARVARD GLOBAL
HEALTH INSTITUTE SAID HE IS
DIRECTOR OF THE HARVARD GLOBAL
HEALTH INSTITUTE SAID HE IS
NERVOUS ABOUT ACTIVITY OVER
HEALTH INSTITUTE SAID HE IS
NERVOUS ABOUT ACTIVITY OVER
LABOR DAY WEEKEND
NERVOUS ABOUT ACTIVITY OVER
LABOR DAY WEEKEND
ABOUT THE MONTHS AHEAD AS THE
LABOR DAY WEEKEND
ABOUT THE MONTHS AHEAD AS THE
WEATHER TURNS FLU SEASON
ABOUT THE MONTHS AHEAD AS THE
WEATHER TURNS FLU SEASON
SETTLES IN. AND PEOPLE PERHAPS
WEATHER TURNS FLU SEASON
SETTLES IN. AND PEOPLE PERHAPS
LET DOWN THEIR GUARD AGAINST
SETTLES IN. AND PEOPLE PERHAPS
LET DOWN THEIR GUARD AGAINST
THE VIRUS. EPIDEMIOLOGIST
LET DOWN THEIR GUARD AGAINST
THE VIRUS. EPIDEMIOLOGIST
DOCTOR JONATHAN KANTOR WITH THE
THE VIRUS. EPIDEMIOLOGIST
DOCTOR JONATHAN KANTOR WITH THE
PENN CENTER FOR EPIDEMIOLOGY
DOCTOR JONATHAN KANTOR WITH THE
PENN CENTER FOR EPIDEMIOLOGY
JOINS ME ONCE AGAIN HERE IN THE
PENN CENTER FOR EPIDEMIOLOGY
JOINS ME ONCE AGAIN HERE IN THE
MORNING SHOW GOOD MORNING.
JOINS ME ONCE AGAIN HERE IN THE
MORNING SHOW GOOD MORNING.
SO WE’RE ON THE HEELS OF A
MORNING SHOW GOOD MORNING.
SO WE’RE ON THE HEELS OF A
HOLIDAY WEEKEND OVER THE
SO WE’RE ON THE HEELS OF A
HOLIDAY WEEKEND OVER THE
MEMORIAL DAY WEEKEND. WE SAW A
HOLIDAY WEEKEND OVER THE
MEMORIAL DAY WEEKEND. WE SAW A
BIG SPIKE DO WORRY ABOUT THE
MEMORIAL DAY WEEKEND. WE SAW A
BIG SPIKE DO WORRY ABOUT THE
SAME THIS LABOR DAY.
>> I THINK THAT’S ABSOLUTELY A
>> I THINK THAT’S ABSOLUTELY A
CONCERN I THINK THAT THE JOBS
>> I THINK THAT’S ABSOLUTELY A
CONCERN I THINK THAT THE JOBS
RIGHT IN SAYING THAT WE’RE
CONCERN I THINK THAT THE JOBS
RIGHT IN SAYING THAT WE’RE
WORRIED ABOUT SITUATIONS WHERE
RIGHT IN SAYING THAT WE’RE
WORRIED ABOUT SITUATIONS WHERE
YOU’RE GOING
WORRIED ABOUT SITUATIONS WHERE
YOU’RE GOING
TO HAVE A LOT MORE SOCIAL
YOU’RE GOING
TO HAVE A LOT MORE SOCIAL
INTERACTIONS REMEMBER CORONA
TO HAVE A LOT MORE SOCIAL
INTERACTIONS REMEMBER CORONA
VIRUSES TEND TO SPEND A LOT
INTERACTIONS REMEMBER CORONA
VIRUSES TEND TO SPEND A LOT
DURING THE SO-CALLED SUPER
VIRUSES TEND TO SPEND A LOT
DURING THE SO-CALLED SUPER
SPREADING EVENTS SO EVENTS
DURING THE SO-CALLED SUPER
SPREADING EVENTS SO EVENTS
WHERE A LOT OF PEOPLE GET
SPREADING EVENTS SO EVENTS
WHERE A LOT OF PEOPLE GET
TOGETHER WHERE THEY REALLY LET
WHERE A LOT OF PEOPLE GET
TOGETHER WHERE THEY REALLY LET
DOWN THEIR GUARD THOSE ARE
TOGETHER WHERE THEY REALLY LET
DOWN THEIR GUARD THOSE ARE
PARTICULARLY CONCERNING NOW ARE
DOWN THEIR GUARD THOSE ARE
PARTICULARLY CONCERNING NOW ARE
WE GOING TO SEE AS MUCH OF A
PARTICULARLY CONCERNING NOW ARE
WE GOING TO SEE AS MUCH OF A
JUMP AS WE SAW AROUND MEMORIAL
WE GOING TO SEE AS MUCH OF A
JUMP AS WE SAW AROUND MEMORIAL
DAY IT’S HARD TO SAY THAT
JUMP AS WE SAW AROUND MEMORIAL
DAY IT’S HARD TO SAY THAT
REALLY COINCIDED WITH BASICALLY
DAY IT’S HARD TO SAY THAT
REALLY COINCIDED WITH BASICALLY
ENDING A LOCKDOWN WHICH PEOPLE
REALLY COINCIDED WITH BASICALLY
ENDING A LOCKDOWN WHICH PEOPLE
SAW AS A CARTE BLANCHE TO
ENDING A LOCKDOWN WHICH PEOPLE
SAW AS A CARTE BLANCHE TO
REALLY GO OUT AND GET MUCH
SAW AS A CARTE BLANCHE TO
REALLY GO OUT AND GET MUCH
MORE ACTIVE WHETHER WE’RE GOING
REALLY GO OUT AND GET MUCH
MORE ACTIVE WHETHER WE’RE GOING
TO SEE AS MUCH OF A SHIFT NOW I
MORE ACTIVE WHETHER WE’RE GOING
TO SEE AS MUCH OF A SHIFT NOW I
DON’T KNOW, BUT CERTAINLY I
TO SEE AS MUCH OF A SHIFT NOW I
DON’T KNOW, BUT CERTAINLY I
THINK IT REALLY IS INCUMBENT
DON’T KNOW, BUT CERTAINLY I
THINK IT REALLY IS INCUMBENT
UPON EVERYBODY TO TAKE THAT
THINK IT REALLY IS INCUMBENT
UPON EVERYBODY TO TAKE THAT
PERSONAL RESPONSIBILITY AND
UPON EVERYBODY TO TAKE THAT
PERSONAL RESPONSIBILITY AND
REMEMBER THAT IT’S GOING HELP
PERSONAL RESPONSIBILITY AND
REMEMBER THAT IT’S GOING HELP
THEMSELVES IN
REMEMBER THAT IT’S GOING HELP
THEMSELVES IN
THEIR COMMUNITY.
THEMSELVES IN
THEIR COMMUNITY.
>>BRUCE HAMILTON: ONCE AGAIN
THEIR COMMUNITY.
>>BRUCE HAMILTON: ONCE AGAIN
THERE’S CONTROVERSY ABOUT
>>BRUCE HAMILTON: ONCE AGAIN
THERE’S CONTROVERSY ABOUT
POLITICIZING DRUG APPROVAL, THE
THERE’S CONTROVERSY ABOUT
POLITICIZING DRUG APPROVAL, THE
HEAD OF THE FDA STEPHEN HAHN
POLITICIZING DRUG APPROVAL, THE
HEAD OF THE FDA STEPHEN HAHN
SAID HE MIGHT APPROVE A
HEAD OF THE FDA STEPHEN HAHN
SAID HE MIGHT APPROVE A
CORONAVIRUS VACCINE. BEFORE
SAID HE MIGHT APPROVE A
CORONAVIRUS VACCINE. BEFORE
PHASE 3 TRIALS ARE COMPLETE.
CORONAVIRUS VACCINE. BEFORE
PHASE 3 TRIALS ARE COMPLETE.
IF THE VACCINE MAKERS THOUGHT
PHASE 3 TRIALS ARE COMPLETE.
IF THE VACCINE MAKERS THOUGHT
THAT THEY
IF THE VACCINE MAKERS THOUGHT
THAT THEY
WERE EFFECTIVE. SO THERE’S SOME
THAT THEY
WERE EFFECTIVE. SO THERE’S SOME
HISTORY HERE WE SAW IT WITH
WERE EFFECTIVE. SO THERE’S SOME
HISTORY HERE WE SAW IT WITH
HYDROXY-CHLORO-QUINN IT WAS NOT
HISTORY HERE WE SAW IT WITH
HYDROXY-CHLORO-QUINN IT WAS NOT
EFFECTIVE GO BACK IN HISTORY
HYDROXY-CHLORO-QUINN IT WAS NOT
EFFECTIVE GO BACK IN HISTORY
1955, THE CUTTER INCIDENT.
EFFECTIVE GO BACK IN HISTORY
1955, THE CUTTER INCIDENT.
THEY APPROVED THE USE OF SOME
1955, THE CUTTER INCIDENT.
THEY APPROVED THE USE OF SOME
POLIO VACCINES. THEY
THEY APPROVED THE USE OF SOME
POLIO VACCINES. THEY
WOUND UP, GIVING A LIVE VACCINE
POLIO VACCINES. THEY
WOUND UP, GIVING A LIVE VACCINE
AND 40,000 KIDS WIND UP GETTING
WOUND UP, GIVING A LIVE VACCINE
AND 40,000 KIDS WIND UP GETTING
POLIO ISN’T THIS DANGEROUS.
>> I THINK THERE’S DEFINITELY A
>> I THINK THERE’S DEFINITELY A
LOT OF CONCERN ABOUT RELEASING
>> I THINK THERE’S DEFINITELY A
LOT OF CONCERN ABOUT RELEASING
ANY KIND OF MEDICATION OR ANY
LOT OF CONCERN ABOUT RELEASING
ANY KIND OF MEDICATION OR ANY
KIND OF TREATMENT BEFORE YOU
ANY KIND OF MEDICATION OR ANY
KIND OF TREATMENT BEFORE YOU
HAVE THE
KIND OF TREATMENT BEFORE YOU
HAVE THE
DATA IN THAT SAID I THINK WE
HAVE THE
DATA IN THAT SAID I THINK WE
HAVE TO KEEP IN MIND THAT FROM
DATA IN THAT SAID I THINK WE
HAVE TO KEEP IN MIND THAT FROM
THE FDA COMMISSIONER
HAVE TO KEEP IN MIND THAT FROM
THE FDA COMMISSIONER
STANDPOINT, YOU’RE SORT OF
THE FDA COMMISSIONER
STANDPOINT, YOU’RE SORT OF
DAMNED IF YOU DO AND DAMNED IF
YOU DON’T BECAUSE IF WE THINK
YOU DON’T BECAUSE IF WE THINK
BACK JUST TO THE 80’S FOR
YOU DON’T BECAUSE IF WE THINK
BACK JUST TO THE 80’S FOR
EXAMPLE THAT DOCTOR FAUCI WAS
BACK JUST TO THE 80’S FOR
EXAMPLE THAT DOCTOR FAUCI WAS
IN A LOT OF TROUBLE WITH SOME
EXAMPLE THAT DOCTOR FAUCI WAS
IN A LOT OF TROUBLE WITH SOME
OF THE AIDS ADVOCACY GROUPS
IN A LOT OF TROUBLE WITH SOME
OF THE AIDS ADVOCACY GROUPS
THAT’S REALLY WHEN THIS FIRST
OF THE AIDS ADVOCACY GROUPS
THAT’S REALLY WHEN THIS FIRST
STARTED THIS IDEA THAT HEY
THAT’S REALLY WHEN THIS FIRST
STARTED THIS IDEA THAT HEY
DON’T KEEP THESE DRUGS THAT MAY
STARTED THIS IDEA THAT HEY
DON’T KEEP THESE DRUGS THAT MAY
BE EFFECTIVE FOR US.
DON’T KEEP THESE DRUGS THAT MAY
BE EFFECTIVE FOR US.
UNAVAILABLE ONLY AVAILABLE IN
BE EFFECTIVE FOR US.
UNAVAILABLE ONLY AVAILABLE IN
THE CLINICAL TRIAL SETTING
UNAVAILABLE ONLY AVAILABLE IN
THE CLINICAL TRIAL SETTING
SO KEEP IN MIND THAT WE ALWAYS
THE CLINICAL TRIAL SETTING
SO KEEP IN MIND THAT WE ALWAYS
ARE DECIDING BASED ON DATA THAT
SO KEEP IN MIND THAT WE ALWAYS
ARE DECIDING BASED ON DATA THAT
ACTUALLY COMES FROM COMPANIES
ARE DECIDING BASED ON DATA THAT
ACTUALLY COMES FROM COMPANIES
ANY MEDICAL ANY MEDICINE
ACTUALLY COMES FROM COMPANIES
ANY MEDICAL ANY MEDICINE
THAT’S APPROVED THE DATA WILL
ANY MEDICAL ANY MEDICINE
THAT’S APPROVED THE DATA WILL
ACTUALLY COME FROM THE COMPANY
THAT’S APPROVED THE DATA WILL
ACTUALLY COME FROM THE COMPANY
AND THEN GO TO THE FDA FOR
ACTUALLY COME FROM THE COMPANY
AND THEN GO TO THE FDA FOR
APPROVAL AND FOR REVIEW, BUT
AND THEN GO TO THE FDA FOR
APPROVAL AND FOR REVIEW, BUT
THAT SAID IT WE’RE TALKING
APPROVAL AND FOR REVIEW, BUT
THAT SAID IT WE’RE TALKING
ABOUT ALLOWING PEOPLE TO USE
THAT SAID IT WE’RE TALKING
ABOUT ALLOWING PEOPLE TO USE
THE VACCINE ON A COMPASSIONATE
ABOUT ALLOWING PEOPLE TO USE
THE VACCINE ON A COMPASSIONATE
USE BASIS OR IF THEY’RE REALLY
THE VACCINE ON A COMPASSIONATE
USE BASIS OR IF THEY’RE REALLY
AT HIGH RISK OF EXPOSURE.
USE BASIS OR IF THEY’RE REALLY
AT HIGH RISK OF EXPOSURE.
THAT’S ONE THING IF WE’RE
AT HIGH RISK OF EXPOSURE.
THAT’S ONE THING IF WE’RE
TALKING ABOUT REALLY TRYING TO
THAT’S ONE THING IF WE’RE
TALKING ABOUT REALLY TRYING TO
ROLL IT OUT TO THE GENERAL
TALKING ABOUT REALLY TRYING TO
ROLL IT OUT TO THE GENERAL
PUBLIC I THINK THAT’S ANOTHER
ROLL IT OUT TO THE GENERAL
PUBLIC I THINK THAT’S ANOTHER
STORY ENTIRELY AND RACE IS MUCH
MORE CONCERTS.
MORE CONCERTS.
>>BRUCE HAMILTON: NOW PRESIDENT
MORE CONCERTS.
>>BRUCE HAMILTON: NOW PRESIDENT
TRUMP’S NEW PANDEMIC ADVISERS
>>BRUCE HAMILTON: NOW PRESIDENT
TRUMP’S NEW PANDEMIC ADVISERS
URGING THE WHITE HOUSE TO ADOPT
TRUMP’S NEW PANDEMIC ADVISERS
URGING THE WHITE HOUSE TO ADOPT
A CONTROVERSIAL NEW IMMUNITY
URGING THE WHITE HOUSE TO ADOPT
A CONTROVERSIAL NEW IMMUNITY
STRATEGY, A HERD IMMUNITY
A CONTROVERSIAL NEW IMMUNITY
STRATEGY, A HERD IMMUNITY
STRATEGY TO COMBAT
STRATEGY, A HERD IMMUNITY
STRATEGY TO COMBAT
THE PANDEMIC ESSENTIALLY WOULD
STRATEGY TO COMBAT
THE PANDEMIC ESSENTIALLY WOULD
ALLOW THE PANDEMIC TO SPREAD
THE PANDEMIC ESSENTIALLY WOULD
ALLOW THE PANDEMIC TO SPREAD
THROUGH THE POPULATION MOST OF
ALLOW THE PANDEMIC TO SPREAD
THROUGH THE POPULATION MOST OF
THE
THROUGH THE POPULATION MOST OF
THE
POPULATION QUICKLY PRESUMABLY
THE
POPULATION QUICKLY PRESUMABLY
TO BUILD RESISTANCE TO THE
POPULATION QUICKLY PRESUMABLY
TO BUILD RESISTANCE TO THE
VIRUS AND THAT IS VERY
TO BUILD RESISTANCE TO THE
VIRUS AND THAT IS VERY
WORRISOME TO PUBLIC HEALTH
VIRUS AND THAT IS VERY
WORRISOME TO PUBLIC HEALTH
OFFICIALS IS THIS SOMETHING
WORRISOME TO PUBLIC HEALTH
OFFICIALS IS THIS SOMETHING
THAT SHOULD EVEN BE ON THE
OFFICIALS IS THIS SOMETHING
THAT SHOULD EVEN BE ON THE
TABLE.
>> WELL, I DON’T THINK THE HERD
>> WELL, I DON’T THINK THE HERD
IMMUNITY APPROACH REALLY SHOULD
>> WELL, I DON’T THINK THE HERD
IMMUNITY APPROACH REALLY SHOULD
BE ON THE TABLE AND I THINK
IMMUNITY APPROACH REALLY SHOULD
BE ON THE TABLE AND I THINK
WE SAW THERE WAS SOME
BE ON THE TABLE AND I THINK
WE SAW THERE WAS SOME
DISCUSSION OF THIS INITIALLY
WE SAW THERE WAS SOME
DISCUSSION OF THIS INITIALLY
WHEN THIS FIRST HAPPENED THE
DISCUSSION OF THIS INITIALLY
WHEN THIS FIRST HAPPENED THE
PEOPLE TALK ABOUT BEFORE THEY
WHEN THIS FIRST HAPPENED THE
PEOPLE TALK ABOUT BEFORE THEY
REALLY KIND OF UNDERSTOOD WHAT
PEOPLE TALK ABOUT BEFORE THEY
REALLY KIND OF UNDERSTOOD WHAT
WAS
REALLY KIND OF UNDERSTOOD WHAT
WAS
GOING ON KEEP IN MIND THAT HERD
WAS
GOING ON KEEP IN MIND THAT HERD
IMMUNITY ONLY WILL KICK IN WHEN
GOING ON KEEP IN MIND THAT HERD
IMMUNITY ONLY WILL KICK IN WHEN
YOU’VE GOT ABOUT 70% OF PEOPLE
IMMUNITY ONLY WILL KICK IN WHEN
YOU’VE GOT ABOUT 70% OF PEOPLE
HAVE BEEN INFECTED WITH THIS
YOU’VE GOT ABOUT 70% OF PEOPLE
HAVE BEEN INFECTED WITH THIS
VIRUS. SO IF YOU JUST DO SOME
HAVE BEEN INFECTED WITH THIS
VIRUS. SO IF YOU JUST DO SOME
ROUGH NUMBERS IF YOU’RE TALKING
VIRUS. SO IF YOU JUST DO SOME
ROUGH NUMBERS IF YOU’RE TALKING
ABOUT 250 MILLION PEOPLE IN THE
UNITED STATES GETTING INFECTED,
UNITED STATES GETTING INFECTED,
IF YOU’VE GOT A ONE PERCENT
UNITED STATES GETTING INFECTED,
IF YOU’VE GOT A ONE PERCENT
RATE OF DEATH THAT’S 2 AND A
IF YOU’VE GOT A ONE PERCENT
RATE OF DEATH THAT’S 2 AND A
HALF MILLION DEATHS
RATE OF DEATH THAT’S 2 AND A
HALF MILLION DEATHS
IF YOU’VE GOT A EVEN IF IT’S
HALF MILLION DEATHS
IF YOU’VE GOT A EVEN IF IT’S
LOWERED TO HALF PERCENT CHANCE
IF YOU’VE GOT A EVEN IF IT’S
LOWERED TO HALF PERCENT CHANCE
OF DEATH THAT’S ONE OF THE
LOWERED TO HALF PERCENT CHANCE
OF DEATH THAT’S ONE OF THE
QUARTER MILLION DEATHS THAT
OF DEATH THAT’S ONE OF THE
QUARTER MILLION DEATHS THAT
YOU’RE GOING TO SEE FROM
QUARTER MILLION DEATHS THAT
YOU’RE GOING TO SEE FROM
THAT APPROACH SO THAT IS SORT
YOU’RE GOING TO SEE FROM
THAT APPROACH SO THAT IS SORT
OF THE LOW TECH APPROACH TO
THAT APPROACH SO THAT IS SORT
OF THE LOW TECH APPROACH TO
SOLVING A VIRAL PROBLEM AND
OF THE LOW TECH APPROACH TO
SOLVING A VIRAL PROBLEM AND
IT’S A REALLY YOU KNOW IN THE
SOLVING A VIRAL PROBLEM AND
IT’S A REALLY YOU KNOW IN THE
YEAR 2020 THAT REALLY IS NOT
IT’S A REALLY YOU KNOW IN THE
YEAR 2020 THAT REALLY IS NOT
THE WAY WE SHOULD BE
VIRAL CONTAINMENT.
VIRAL CONTAINMENT.
>>BRUCE HAMILTON: AND FINALLY
VIRAL CONTAINMENT.
>>BRUCE HAMILTON: AND FINALLY
FLORIDA’S GOVERNOR TALKED ABOUT
>>BRUCE HAMILTON: AND FINALLY
FLORIDA’S GOVERNOR TALKED ABOUT
NOT REPORTING THE NUMBER OF
FLORIDA’S GOVERNOR TALKED ABOUT
NOT REPORTING THE NUMBER OF
STUDENTS WHO
NOT REPORTING THE NUMBER OF
STUDENTS WHO
ARE ASYMPTOMATIC ISN’T THAT
STUDENTS WHO
ARE ASYMPTOMATIC ISN’T THAT
RISKY BECAUSE CANT INFECT
ARE ASYMPTOMATIC ISN’T THAT
RISKY BECAUSE CANT INFECT
SOMEBODY WHO DOES DEVELOP
RISKY BECAUSE CANT INFECT
SOMEBODY WHO DOES DEVELOP
SYMPTOMS OR INFECT SOMEBODY
SOMEBODY WHO DOES DEVELOP
SYMPTOMS OR INFECT SOMEBODY
WITH UNDERLYING CONDITIONS.
>> I THINK YOU KNOW ONE OF THE
>> I THINK YOU KNOW ONE OF THE
CONCERNS ABOUT CORONAVIRUS IS
>> I THINK YOU KNOW ONE OF THE
CONCERNS ABOUT CORONAVIRUS IS
THAT YOU KNOW WE HAD THE
CONCERNS ABOUT CORONAVIRUS IS
THAT YOU KNOW WE HAD THE
SHIFTING DATA RIGHT IN THE
THAT YOU KNOW WE HAD THE
SHIFTING DATA RIGHT IN THE
BEGINNING WE HAD ALL THIS
SHIFTING DATA RIGHT IN THE
BEGINNING WE HAD ALL THIS
INFORMATION COMING FROM CHINA
BEGINNING WE HAD ALL THIS
INFORMATION COMING FROM CHINA
THAT YOU HAVE TO BE SICK YET
INFORMATION COMING FROM CHINA
THAT YOU HAVE TO BE SICK YET
THAT FEVER AND THAT’S WHY WE’RE
THAT YOU HAVE TO BE SICK YET
THAT FEVER AND THAT’S WHY WE’RE
SO INTO TEMPERATURE CHECKS AND
THAT FEVER AND THAT’S WHY WE’RE
SO INTO TEMPERATURE CHECKS AND
MAKING SURE PEOPLE
SO INTO TEMPERATURE CHECKS AND
MAKING SURE PEOPLE
IN SYMPTOMATIC BUT AS DATA
MAKING SURE PEOPLE
IN SYMPTOMATIC BUT AS DATA
EMERGED SHOWING THAT YOU CAN
IN SYMPTOMATIC BUT AS DATA
EMERGED SHOWING THAT YOU CAN
HAVE A SIGNIFICANT AMOUNT OF
EMERGED SHOWING THAT YOU CAN
HAVE A SIGNIFICANT AMOUNT OF
ASYMPTOMATIC SPREAD YOU GET THE
HAVE A SIGNIFICANT AMOUNT OF
ASYMPTOMATIC SPREAD YOU GET THE
STORIES OF KIDS GETTING IT
ASYMPTOMATIC SPREAD YOU GET THE
STORIES OF KIDS GETTING IT
NOT REALLY GETTING SICK
STORIES OF KIDS GETTING IT
NOT REALLY GETTING SICK
THEMSELVES AND SPREADING INTO
NOT REALLY GETTING SICK
THEMSELVES AND SPREADING INTO
THEIR WHOLE FAMILY I THINK THAT
THEMSELVES AND SPREADING INTO
THEIR WHOLE FAMILY I THINK THAT
RAISES A LOT MORE CONCERNS I
THEIR WHOLE FAMILY I THINK THAT
RAISES A LOT MORE CONCERNS I
THINK THE IDEA THAT WE SHOULD
RAISES A LOT MORE CONCERNS I
THINK THE IDEA THAT WE SHOULD
NOT COUNT SOMEBODY BECAUSE
THINK THE IDEA THAT WE SHOULD
NOT COUNT SOMEBODY BECAUSE
THEY’RE ASYMPTOMATIC I THINK
NOT COUNT SOMEBODY BECAUSE
THEY’RE ASYMPTOMATIC I THINK
THAT DOESN’T REALLY FIT WITH A
THEY’RE ASYMPTOMATIC I THINK
THAT DOESN’T REALLY FIT WITH A
LOT OF THE SCIENCE THAT’S BEEN
THAT DOESN’T REALLY FIT WITH A
LOT OF THE SCIENCE THAT’S BEEN
COMING OUT LATELY.
LOT OF THE SCIENCE THAT’S BEEN
COMING OUT LATELY.
>> DOCTOR JONATHAN KANTOR,
COMING OUT LATELY.
>> DOCTOR JONATHAN KANTOR,
ALWAYS APPRECIATE YOUR
